Received Jul 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (DAPTACEL) | SANOFI PASTEUR | UNK | 3CA11C1 | OT / LA |
| TDAP | TDAP (ADACEL) | SANOFI PASTEUR | UNK | — | OT |
patient was supposed to received ADACEL but received DAPTACEL instead with no reported adverse event; Initial information received on 22-Jul-2025 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 29 years old male patient who was supposed to received diphtheria-2/tetanus/5 Ac pertussis vaccine [Adacel] but instead received diphtheria-15/tetanus/5 Ac pertussis vaccine [Daptacel] with no reported adverse event. The patient's past medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided. No other vaccine. On 22-Jul-2025 at 08:55 AM, the patient supposed to received diphtheria-2/tetanus/5 Ac pertussis vaccine but instead received 0.5 ml of suspect diphtheria-15/tetanus/5 AC pertussis vaccine Suspension for injection of standard strength, frequency once with lot 3CA11C1 and expiry date 31-Dec-2025 via intramuscular route in the left deltoid for immunization with no reported adverse event (wrong product administered) (Latency same day) Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.